George Harrison Talbot, Director at Nabriva Therapeutics AG (NBRV), sold 325 shares at $99.70 ($33K) on 2017-05-23, disclosed to the SEC on 2017-05-25.
Open-market sale of $33k NBRV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.70 | 30 | $3K | 9.2% |
| 2 | $100.50 | 205 | $21K | 63.0% |
| 3 | $101.00 | 90 | $9K | 27.8% |
| Total | $100.56 avg | 325 | $33K | 100% |
| Filing → |
| NBRV | SELL | 2017-06-01 | $21K | — | Filing → |
| NBRV | SELL | 2017-05-17 | $21K | — | Filing → |